Microbial biofilms in osteomyelitis of the jaw and osteonecrosis of the jaw secondary to bisphosphonate therapy.
about
Medication Related Osteonecrosis of the Jaw: 2015 Position Statement of the Korean Society for Bone and Mineral Research and the Korean Association of Oral and Maxillofacial SurgeonsOsteochemonecrosis: an overviewActinomyces and related organisms in human infectionsUse of Ultrasonic Bone Surgery (Piezosurgery) to Surgically Treat Bisphosphonate-Related Osteonecrosis of the Jaws (BRONJ). A Case Series Report with at Least 1 Year of Follow-Up.Antibiotic effects on bacterial profile in osteonecrosis of the jawMolecular profiling of oral microbiota in jawbone samples of bisphosphonate-related osteonecrosis of the jaw.Updates on osteonecrosis of the jawLack of correlation between duration of osteonecrosis of the jaw and sequestra tissue morphology: what it tells us about the condition and what it means for future studiesStaphylococcus aureus biofilms decrease osteoblast viability, inhibits osteogenic differentiation, and increases bone resorption in vitroUse of bisphosphonates and the risk of osteonecrosis among cancer patients: a systemic review and meta-analysis of the observational studies.Closure of an open wound associated with bisphosphonate-related osteonecrosis of the jaw in a breast cancer patientOrthopaedic biofilm infections.Bad to the Bone: On In Vitro and Ex Vivo Microbial Biofilm Ability to Directly Destroy Colonized Bone Surfaces without Participation of Host Immunity or Osteoclastogenesis.Oral care and the use of bone-targeted agents in patients with metastatic cancers: A practical guide for dental surgeons and oncologists.Metagenomic investigation of microbes and viruses in patients with jaw osteonecrosis associated with bisphosphonate therapy.Pathophysiology of Osteonecrosis of the Jaws.Oral microbiota and host innate immune response in bisphosphonate-related osteonecrosis of the jaw.Periodontal disease as a risk factor for bisphosphonate-related osteonecrosis of the jaw.A systematic review of bisphosphonate osteonecrosis (BON) in cancer.The immune system vs. Pseudomonas aeruginosa biofilms.Osteonecrosis of the jaw and bisphosphonates in cancer: a narrative review.Pathophysiology of atypical femoral fractures and osteonecrosis of the jaw.Osteopathology associated with bone resorption inhibitors - which role does Actinomyces play? A presentation of 51 cases with systematic review of the literature.Current pharmacotherapy options for osteomyelitis: convergences, divergences and lessons to be drawn.Actinomyces osteomyelitis in bisphosphonate-related osteonecrosis of the jaw (BRONJ): the missing link?Hyperbaric oxygen therapy and osteonecrosis.Elevation of pro-inflammatory cytokine levels following anti-resorptive drug treatment is required for osteonecrosis development in infectious osteomyelitis.Impaired respiration elicits SrrAB-dependent programmed cell lysis and biofilm formation in Staphylococcus aureus.Fungal contribution in chondroradionecrosis of the larynx.Biofilm colonization in chronic treatment refractory infections presenting with discharging sinuses: A study in a tertiary care hospital of Eastern India.YM-175 induces apoptosis of human native monocyte-lineage cells via inhibition of prenylation.The role of bacterial biofilms in chronic infections.A Case of Pentastomiasis at the Left Maxilla Bone in a Patient with Thyroid Cancer.SaeRS Is Responsive to Cellular Respiratory Status and Regulates Fermentative Biofilm Formation in Staphylococcus aureus.Biofilm in Osteomyelitis caused by a Rare Pathogen, Morganella morganii : A Case Report.IL-17-mediated M1/M2 macrophage alteration contributes to pathogenesis of bisphosphonate-related osteonecrosis of the jaws.Microbial biofilms are able to destroy hydroxyapatite in the absence of host immunity in vitro.Macrophages and bisphosphonate-related osteonecrosis of the jaw (BRONJ): evidence of local immunosuppression of macrophages in contrast to other infectious jaw diseases.An experimental study of bisphosphonate-induced jaws osteonecrosis in Sprague-Dawley rats.Clinical experience with spiramycin in bisphosphonate-associated osteonecrosis of the jaw.
P2860
Q26771715-8C3FF6D3-3E3D-472B-95CE-F3BAA8FE3A15Q26827072-6160CFA4-98A1-444F-97A7-3BA9B52678E0Q27028059-C721DB7C-0FC4-4AF2-8C76-63A4BD4AA449Q30449286-E6E2BCE4-D01C-4FAA-A560-9C616835E2A6Q34007581-880E2BB9-5F14-420B-9DD3-60DFB13BF844Q34207408-7521B063-DEAB-4AB9-8B68-6F343AEA9C49Q34234108-1568B7CE-B5EC-42B6-87E5-AF3E3A9467EBQ34238507-D4207BC2-4406-446D-9960-7EE97D50AC9BQ34773424-DD52A3C2-423C-4DEB-9C1C-612DAA86E0D8Q35033859-47482A10-DD39-4EF4-8B98-EF8C83E4F954Q35583602-A89CDEEC-65A7-4335-ABA9-7BC3601E6F49Q35738493-937A5B6C-CE7D-4651-8657-5F722B25B160Q36246239-72A67F87-C1ED-431E-A011-CC488F01EF4CQ36491413-6BC7326C-291E-45B1-B96C-AED478730859Q36567433-D799B066-60D6-4990-A7FB-5A34EB89DFF3Q37006852-C2D9DAB2-7DAC-4D57-AD6C-5782E70A6156Q37497384-D007AA7D-0A84-4C29-B062-21898BE09F2DQ37678922-725ADF9D-5E0A-4246-8034-E4D7410A4556Q37735736-652DAD24-0DEB-4C1F-90E8-78A8376BA0A1Q37767747-09A79C73-8439-4860-8F47-44222A89AD84Q37809735-53D53132-3CE8-4941-9F59-F34A3CBA3CB7Q37945476-ACA80C81-29C9-44AA-A36A-F9118EFD84A6Q38078076-55FE8C35-99C5-4266-844B-1322B27FBE79Q38089918-3BE7F806-B7B4-4753-957E-35476C223016Q38216355-0B8F0FFC-D07E-417D-80D9-A437201D0A0BQ38803408-E31260EF-1DB7-4C4C-9D5B-0E07BF77A450Q38848433-391D8871-0F18-4E09-90EB-08396A724D12Q38950493-1B68AD3F-9949-4804-8CBF-46104F8B7B1AQ38964050-B2E4805A-D8D0-4EF4-8ED3-90CDF7CFEBB8Q39157530-021CFE33-D89B-4098-9BAD-E10B50833FDBQ39264030-218F1A55-F835-4D1F-A152-BD1B52FBF833Q39426830-B2B329A7-7CEA-49EC-8303-149B952791B6Q40064245-F29FEF35-67D1-4D45-964C-5933983FE2FCQ40211756-17110BD0-DD41-4434-A3FF-36B4A4E27E02Q40582987-DBBEFF38-27D1-41D4-8188-FB61B0EE65C7Q41426868-402B1CCB-0084-4BFD-A837-B46F675912AFQ41579307-D3A3A328-DBED-4079-B2BA-2B85D809471BQ42209228-5CF6F0EF-D305-49E3-938F-FE62DB67466EQ42916904-239112B8-6A04-4CD5-96AF-23FBF85F6C55Q42964141-F506C159-9577-4385-AA6B-EBEEBC11B78F
P2860
Microbial biofilms in osteomyelitis of the jaw and osteonecrosis of the jaw secondary to bisphosphonate therapy.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Microbial biofilms in osteomye ...... ary to bisphosphonate therapy.
@en
Microbial biofilms in osteomye ...... ary to bisphosphonate therapy.
@nl
type
label
Microbial biofilms in osteomye ...... ary to bisphosphonate therapy.
@en
Microbial biofilms in osteomye ...... ary to bisphosphonate therapy.
@nl
prefLabel
Microbial biofilms in osteomye ...... ary to bisphosphonate therapy.
@en
Microbial biofilms in osteomye ...... ary to bisphosphonate therapy.
@nl
P2093
P1476
Microbial biofilms in osteomye ...... ary to bisphosphonate therapy.
@en
P2093
Amita Gorur
Charles F Shuler
Christoph Schaudinn
J William Costerton
Parish P Sedghizadeh
P304
P356
10.14219/JADA.ARCHIVE.2009.0049
P407
P50
P577
2009-10-01T00:00:00Z